Bold to the bone

Choose BILDYOS, a biosimilar as safe and effective as PROLIA (denosumab)

Bold to the bone

Meet BILDYOS

BILDYOS is highly similar to PROLIA (denosumab)

Biologic osteoporosis treatment may be expensive. PROLIA is one of the more costly medications covered by Medicare.

A biosimilar option may lower treatment costs

The wholesale acquisition cost (WAC) for BILDYOS is ~55% less expensive than PROLIA.*

Cost and coverage for BILDYOS is dependent on the terms and conditions of your individual insurance benefits, including any applicable deductible, co-insurance, or co-payment.

* Based on comparison of WAC per injection. WAC prices: BILDYOS $844.00 per injection; PROLIA $1,875.43 per injection (Source: Medi-Span® Price Rx® as of Sept 2025). WAC, also known as list price, is the price of a medication set by a pharmaceutical manufacturer when selling their product to a wholesaler.
BILDYOS
PROLIA
Meets strict FDA standards for approval
5 approved uses
Highly similar safety and effectiveness
Strengthens bone and protects against fractures
1 injection every 6 months

FDA, US Food and Drug Administration.

BILDYOS is a biosimilar to PROLIA,
meaning it is a highly similar alternative

BILDYOS is a prescription medicine used to treat osteoporosis (thinning and weakening of bone) in women after menopause who:

Bone icon

are at high risk for fracture (broken bone)

Medicine icon

cannot use another osteoporosis medicine or for whom other medicines did not work well

  • Increase bone mass in men with osteoporosis who are at high risk for fracture
  • Treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least 6 months and are at high risk for fracture
  • Treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body
  • Treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body

It is not known if BILDYOS is safe and effective in children. BILDYOS is not approved for use in children.

Biosimilars work the same way as the original biologic, at a potentially lower cost

Biosimilars work the same way as the original biologic, at a potentially lower cost

Biosimilars like BILDYOS can provide patients with more treatment options

A biosimilar is an FDA-approved medicine that is highly similar to the original biologic medicine it is based on. Biologic medicines are complex. Biosimilars are not exact copies, but they go through a strict FDA-approval process to make sure they are just as safe and effective as the original biologic. A biosimilar works the same way in the body as the original biologic. Biosimilars may also be available at a lower cost than the original biologics.

Cost and coverage for specific biosimilars are dependent on the terms and conditions of your individual insurance benefits, including any applicable deductible, co-insurance, or co-payment.

A biosimilar works in your body in the same way as the biologic it’s based on, offering the same treatment benefits and potential side effects

BILDYOS is brought to you by Organon Biosimilars

We are an experienced biosimilar company with:

8+

years dedicated to biosimilars in the US

6

biosimilars approved in the US and still counting

5

therapeutic areas treated:

Card ImageCancer care
Card ImageGut conditions
Card ImageSkin conditions
Card ImageJoint and autoimmune conditions
Card ImageBone health

Organon is dedicated to making a difference in women’s health,
through biosimilars and beyond

Learn how BILDYOS is administered and things to keep in mind during treatment

See what to expect
Learn how BILDYOS is administered and things to keep in mind during treatment